Evidence map›Paper›PMID 38027301›Full record

ArticleFrontiers in pediatrics2023

Case Report: Guanfacine and methylphenidate improved chronic lower back pain in autosomal dominant polycystic kidney disease with comorbid attention deficit hyperactivity disorder and autism spectrum disorder.

Satoshi Kasahara, Shoichiro Kanda, Miwako Takahashi, Mao Fujioka, Taito Morita, Ko Matsudaira, Naoko Sato, Motoshi Hattori, Toshimitsu Momose, Shin-Ichi Niwa and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Satoshi KasaharaDepartment of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, Japan.
Shoichiro KandaDepartment of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Miwako TakahashiInstitute for Quantum Medical Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
Mao FujiokaDepartment of Neuropsychiatry, The University of Tokyo Hospital, Tokyo, Japan.
Taito MoritaDepartment of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, Japan.
Ko MatsudairaDepartment of Pain Medicine, Fukushima Medical University School of Medicine, Fukushima, Japan.
Naoko SatoNursing Department, The University of Tokyo Hospital, Tokyo, Japan.
Motoshi HattoriDepartment of Pediatric Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
Toshimitsu MomoseInstitute of Engineering Innovation, School of Engineering, The University of Tokyo, Tokyo, Japan.
Shin-Ichi NiwaDepartment of Psychiatry, Aizu Medical Center, Fukushima Medical University, Fukushima, Japan.
Kanji UchidaDepartment of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo, Japan.
University of Tokyo Hospital · JPFukushima Medical University · JPThe University of Tokyo · JPNational Institutes for Quantum and Radiological Science and Technology · JPTokyo Women's Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is an inherited renal disease characterized by the bilateral development of multiple cysts in the kidneys. Pain management is a clinically important issue, especially because approximately 60% of patients with ADPKD experience chronic pain related to hemorrhage from renal cysts, which significantly reduces their daily life. The cystic fibrosis transmembrane conductance regulator, the molecule responsible for cyst formation in ADPKD, is also the cause of cystic fibrosis. Since attention deficit hyperactivity disorder (ADHD) is known to occur frequently in conjunction with cystic fibrosis, ADPKD may be associated with ADHD. However, to our knowledge, no study has investigated 1) ADHD or autism spectrum disorder (ASD) as comorbidities with ADPKD, 2) the effects of ADHD medications on chronic pain in ADPKD, or 3) cerebral blood flow corresponding to guanfacine (GF) or methylphenidate (MP) treatment for chronic pain. We report the case of a 15-year-old girl with ADPKD, who had chronic back pain associated with ADPKD and had to withdraw from high school because the pain interfered with her daily life. Although she took antihypertensive medications to prevent bleeding, they did not provide adequate blood pressure control. The patient was referred to a child psychiatrist and diagnosed with ASD; however, the pain did not improve. Subsequently, she was referred to our pain center. The diagnosis of ADHD was confirmed and treatment with ADHD medications was initiated. Monotherapy with MP, atomoxetine, and GF resulted in hypertension and hypotension as side effects; however, a combination of MP 18 mg and GF 4 mg provided pain relief and moderate blood pressure control, and the patient was able to go on to college. During the course of treatment, there was an improvement in the distribution of cerebral blood flow in the prefrontal and insular cortices. Confirmation of an ADHD diagnosis comorbid with ASD enabled the use of ADHD medications. The combination of MP and GF improved chronic back pain and high blood pressure due to ADPKD and cerebral blood flow. Screening for ADHD is important in the treatment of ADPKD.

Indexed as

attention deficit hyperactivity disorderautism spectrum disorderautosomal dominant polycystic kidney diseasecerebral blood flowcystic fibrosis transmembrane conductance regulatorguanfacinelower back painmethylphenidate

Identifiers

PMID38027301
PMCPMC10646415
OpenAlexW4388127072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.